Benzinga - Jun 3, 2021, 11:08AM
Benzinga - Apr 14, 2021, 3:15PM
load more
BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies.

Related Companies

TickerCompanyChg %Mkt Cap
BCTXBriaCell Therapeutics-1.21%

BriaCell Therapeutics Frequently Asked Questions

Q

How do I buy BriaCell Therapeutics (BCTX) stock?

A

You can purchase shares of BriaCell Therapeutics (NASDAQ: BCTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BriaCell Therapeutics's (BCTX) competitors?

A

There are no as such competitors for BriaCell Therapeutics.

Q

What is the target price for BriaCell Therapeutics (BCTX) stock?

A

There is no analysis for BriaCell Therapeutics

Q

Current Stock Price for BriaCell Therapeutics (BCTX)?

A

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $5.72 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does BriaCell Therapeutics (BCTX) pay a dividend?

A

There are no upcoming dividends for BriaCell Therapeutics.

Q

When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?

A

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Q

Is BriaCell Therapeutics (BCTX) going to split?

A

There is no upcoming split for BriaCell Therapeutics.

Q

What sector and industry does BriaCell Therapeutics (BCTX) operate in?

A

BriaCell Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.